Neothetics Priced, Nasdaq: NEOT
Developing an injectable version of an approved asthma drug to reduce belly fat.
Industry: Health Care
First Day Return: -14.3%
Industry: Health Care
NEOT
Developing an injectable version of an approved asthma drug to reduce belly fat.
| IPO Data | |
|---|---|
| IPO File Date | 10/17/2014 |
| Offer Price | $14.00 |
| Price Range $13.00 - $15.00 | |
| Offer Shares (mm) | 4.7 |
| Deal Size ($mm) | $65 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 11/19/2014 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $65 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | San Diego, CA, United States |
| Founded | 2007 |
| Employees at IPO | 9 |
| Website www.neothetics.com | |
Neothetics (NEOT) Performance
